ELOX Eloxx Pharmaceuticals Inc.

11.61
-0.09  -1%
Previous Close 11.7
Open 12.2
Price To Book 9.68
Market Cap 416335924
Shares 35,860,114
Volume 17,673
Short Ratio
Av. Daily Volume 30,512

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 1b MAD final cohort to be completed 1H 2019.
ELX-02
Multiple-ascending dose (MAD)
Phase 2 data due 2019.
ELX-02
Cystic fibrosis

Latest News

  1. Eloxx Pharmaceuticals to Present at the Guggenheim Rare Disease & Genomic Medicines Day on April 2, 2019
  2. Edited Transcript of ELOX earnings conference call or presentation 8-Mar-19 1:00pm GMT
  3. Eloxx Pharmaceuticals, Inc. (ELOX) Q4 2018 Earnings Conference Call Transcript
  4. Eloxx Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial and Operating Results and Provides Business Update
  5. Eloxx Pharmaceuticals to Present at the Oppenheimer 29th Annual Healthcare Conference on March 20, 2019
  6. Eloxx Pharmaceuticals Announces Participation in the HIT-CF Project on Cystic Fibrosis
  7. Eloxx Pharmaceuticals to Present at the Barclays Global Healthcare Conference on March 14, 2019
  8. Eloxx Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference on Monday, March 11, 2019
  9. Eloxx Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference in New York City on Friday, March 1, 2019
  10. Eloxx Pharmaceuticals to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Business Update on March 8, 2019
  11. Eloxx Pharmaceuticals to Present at the 2019 BIO CEO and Investor Conference in New York City on Monday, February 11, 2019
  12. Eloxx Pharmaceuticals to Participate in a Panel Discussion at the BIOTECH SHOWCASE™ in San Francisco on Wednesday, January 9, 2019
  13. Could The Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Ownership Structure Tell Us Something Useful?
  14. Waltham's Eloxx aims to reach cystic fibrosis patients that Vertex can't
  15. Edited Transcript of ELOX earnings conference call or presentation 8-Nov-18 1:30pm GMT
  16. Eloxx Pharmaceuticals To Present at the 30th Annual Piper Jaffray Healthcare Conference on Wednesday, November 28, 2018
  17. Eloxx Pharmaceuticals To Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27, 2018
  18. Eloxx Pharmaceuticals Reports Third Quarter 2018 Financial and Operating Results and Provides Business Update